logo

Daniel Chan

0 Reviews Add Your Review

Icon SOC

820 Thomson Road #05-03/04, Mt Alvernia Medical Centre Blk A, Singapore 574623

Get a consultation Give Feedback
Icon SOC

820 Thomson Road #05-03/04, Mt Alvernia Medical Centre Blk A, Singapore 574623

View Map

Mon - Fri
8.30am – 5.30pm
Sat
Closed
Sun
Closed

book appointment

About


Dr Chan graduated with the rare distinction of honours from National University of Singapore (NUS) School of Medicine. He was further trained in internal medicine and obtained the MRCP (UK) in 2004. He received his medical oncology specialist training with the National University Cancer Institute of Singapore. He finished his final year of fellowship in the USA at the prestigious University of California, Los Angeles (UCLA) and Cedars- Sinai Medical Centre. He honed his medical oncology clinical expertise at UCLA and Cedars-Sinai with Dr Ronald Natale (lung cancer), Dr Michael Lill (lymphoma), Dr Charles Forscher (sarcoma) and Dr Albert Lai (neuro-oncology) under an endowment grant from the National University Hospital of Singapore. He also pursued research in the laboratory of world-famous haematologist-oncologist Professor Phillip Koeffler under a National Medical Research Council Overseas Fellowship.

Upon his return, he was a consultant in medical oncology at the National University Cancer Institute Singapore and director of undergraduate education (medical oncology) at the National University of Singapore. He was also actively involved in cancer research at the Cancer Science Institute Singapore. He is a member of the American Society of Clinical Oncology, and in 2015 he was elected to be a fellow in the Royal College of Physicians Edinburgh.

Achievements and Accolades

Published in international peer reviewed journals including Proceedings of the National Academy of Sciences (USA), Annals of Oncology and Investigational New Drugs on breast cancer, melanoma, thyroid cancer, nasopharyngeal cancer and myeloproliferative neoplasms.
Written a book chapter on breast cancer in “Oncogene and Cancer – From Bench to Clinic“
Was involved as a co-investigator in numerous trials of new oncology drugs and held a national research grant in triple-negative breast cancer in NCIS.
Awarded the Excellent Service Award (EXSA) and STAR award (from SPRING Singapore) on multiple occasions for exemplary service to his patients.
First in South Asia to use the PD-1 immunotherapy drug (Pembrolizumab) in clinical practice
Sub specialty interests: Breast, lung and colon cancers, lymphoma, neuro-oncology and sarcoma

reviews


Write a review
Submit Review

Procedures


  • Chemotherapy
  • Haematology
  • Cancer Screening and Diagnosis

Education


  • MBBS (Honours) 2000 –National University of Singapore School of Medicine
  • MRCP (UK) 2004 –Royal College of Physicians United Kingdom
  • FAMS (Medical Oncology) 2009 –Academy of Medicine Singapore
  • FRCP (Edinburgh) 2015 – Royal College of Physicians Edinburgh

About


Dr Chan graduated with the rare distinction of honours from National University of Singapore (NUS) School of Medicine. He was further trained in internal medicine and obtained the MRCP (UK) in 2004. He received his medical oncology specialist training with the National University Cancer Institute of Singapore. He finished his final year of fellowship in the USA at the prestigious University of California, Los Angeles (UCLA) and Cedars- Sinai Medical Centre. He honed his medical oncology clinical expertise at UCLA and Cedars-Sinai with Dr Ronald Natale (lung cancer), Dr Michael Lill (lymphoma), Dr Charles Forscher (sarcoma) and Dr Albert Lai (neuro-oncology) under an endowment grant from the National University Hospital of Singapore. He also pursued research in the laboratory of world-famous haematologist-oncologist Professor Phillip Koeffler under a National Medical Research Council Overseas Fellowship.

Upon his return, he was a consultant in medical oncology at the National University Cancer Institute Singapore and director of undergraduate education (medical oncology) at the National University of Singapore. He was also actively involved in cancer research at the Cancer Science Institute Singapore. He is a member of the American Society of Clinical Oncology, and in 2015 he was elected to be a fellow in the Royal College of Physicians Edinburgh.

Achievements and Accolades

Published in international peer reviewed journals including Proceedings of the National Academy of Sciences (USA), Annals of Oncology and Investigational New Drugs on breast cancer, melanoma, thyroid cancer, nasopharyngeal cancer and myeloproliferative neoplasms.
Written a book chapter on breast cancer in “Oncogene and Cancer – From Bench to Clinic“
Was involved as a co-investigator in numerous trials of new oncology drugs and held a national research grant in triple-negative breast cancer in NCIS.
Awarded the Excellent Service Award (EXSA) and STAR award (from SPRING Singapore) on multiple occasions for exemplary service to his patients.
First in South Asia to use the PD-1 immunotherapy drug (Pembrolizumab) in clinical practice
Sub specialty interests: Breast, lung and colon cancers, lymphoma, neuro-oncology and sarcoma

reviews


Write a review
Submit Review

Procedures


  • Chemotherapy
  • Haematology
  • Cancer Screening and Diagnosis

Education


  • MBBS (Honours) 2000 –National University of Singapore School of Medicine
  • MRCP (UK) 2004 –Royal College of Physicians United Kingdom
  • FAMS (Medical Oncology) 2009 –Academy of Medicine Singapore
  • FRCP (Edinburgh) 2015 – Royal College of Physicians Edinburgh